down arrow

Livzon Pharmaceutical Group, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001QV5
HKD
21.78
-9.97 (-31.4%)

Sep 23

HKG

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Livzon Pharmaceutical Group, Inc. stock-summary
stock-summary
Livzon Pharmaceutical Group, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
2,450 Million
(Quarterly Results - Jun 2026)
Net Profit:
457 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

HKD 6,530 Million ()

stock-summary
P/E

3.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.39

stock-summary
Return on Equity

14.16%

stock-summary
Price to Book

0.42

Footer loading